跳至主要内容
临床试验/CTRI/2026/02/103348
CTRI/2026/02/103348尚未招募2/3 期

Randomized controlled clinical study to assess the add-on effect of Mishreya (Foeniculum vulgare) Ark ashchyotan with Timolol eye drops in primary open angle glaucoma (POAG) with special reference to Kaphaja Adhimantha.

Ayurved Vidya Prasarak Mandals Ayurved Mahavidyalay, Sion1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2026年2月19日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
114
试验地点
1
主要终点
1. To assess the changes in subjective symptoms of POAG (Kaphaj Adhimantha) in group A and group B.

研究概览

简要总结

Patients with POAG (Kaphaj Adhimantha ) will be informed about the trial and written consent will be taken. Interventions to both the groups will be given.

assessment will be done based on

subjective criteria

  1. headache

  2. ocular pain

  3. difficulty in near vision

objective criteria

  1. BCVA

  2. IOP

  3. MD of perimetry

  4. NPA on RAF rule.

Data will be obtained and stastistical analysis will be done. Observations and

results will be done based on statistical analysis.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 40 -70 years old patient of POAG, with IOP less than 30 mm of Hg, CDR less than 0.7, visual acuity more than 6/60.

排除标准

  • Patients with all types of PCAG, cataract, secondary and developmental glaucoma including exfoliative glaucoma, pigmentary glaucoma, trauma induced inflammatory glaucoma, advanced glaucomatous optic neuropathy or optic atrophy.
  • Visual acuity less than 6/60
  • known cases of bronchial asthma, cardiac diseas or patient on steroid treatment.

结局指标

主要结局

1. To assess the changes in subjective symptoms of POAG (Kaphaj Adhimantha) in group A and group B.

时间窗: at baseline, 10th day, 20th day, 30th day, 60th day

2. To assess the pre and post study changes in BCVA, IOP, MD in Perimetry, NPA in RAF rule in group A and group B.

时间窗: at baseline, 10th day, 20th day, 30th day, 60th day

3. To study the efficacy of Mishreya Ark Ashchyotan and Timolol eye drops in POAG.

时间窗: at baseline, 10th day, 20th day, 30th day, 60th day

次要结局

  • 3. To study Mishreya ark in detail(4. To study Ashchyotan in deatil and prepare its SOP.)

研究者

发起方
Ayurved Vidya Prasarak Mandals Ayurved Mahavidyalay, Sion
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Dipti Nene

Ayurved Vidya Prasarak Mandals Ayurved Mahavidyalay, Sion

研究点 (1)

Loading locations...

相似试验